未登录 Subcutaneous batoclimab in generalized myasthenia gravis: Results from a Phase 2a trial with an open-label extension Nowak, Richard J.; Breiner, Ari; Bril, Vera; Allen, Jeffrey A.; Khan, Shaida; Levine, Todd; Jacobs, Daniel H.; Sahagian, Gregory; Siddiqi, Zaeem A.; Xu, Jing; Macias, William L.; Benatar, Michael 分享 收藏
Proof-of-concept and Randomized, Placebo-controlled Trials of an FcRn Inhibitor, Batoclimab, for Thyroid Eye Disease Kahaly, George J.; Dolman, Peter J.; Wolf, Jan; Giers, Bert C.; Elflein, Heike M.; Jain, Amy P.; Srinivasan, Ashok; Hadjiiski, Lubomir; Jordan, David; Bradley, Elizabeth A.; Stan, Marius N.; Eckstein, Anja; Pitz, Susanne; Vorlaender, Christian; Wester, Sara T.; Nguyen, John; Tucker, Nancy; Sales-Sanz, Marco; Feldon, Steven E.; Nelson, Christine C.; Hardy, Isabelle; Abia-Serrano, Maravillas; Tedeschi, Philip; Janes, Jonathan M.; Xu, Jing; Vue, Peter; Macias, William L.; Douglas, Raymond S. 分享 收藏
MRI and Dose Selection in a Phase II Trial of Baricitinib with Conventional Synthetic Disease-modifying Antirheumatic Drugs in Rheumatoid Arthritis Baricitinib与常规合成的缓解疾病的抗风湿药物在类风湿关节炎中的II期试验中的MRI和剂量选择 Peterfy, Charles; DiCarlo, Julie; Emery, Paul; Genovese, Mark C.; Keystone, Edward C.; Taylor, Peter C.; Schlichting, Doug E.; Beattie, Scott D.; Luchi, Monica; Macias, William 分享 收藏
Characterization and Changes of Lymphocyte Subsets in Baricitinib-Treated Patients With Rheumatoid Arthritis An Integrated Analysis Tanaka, Yoshiya; McInnes, Iain B.; Taylor, Peter C.; Byers, Nicole L.; Chen, Lei; de Bono, Stephanie; Issa, Maher; Macias, William L.; Rogai, Veronica; Rooney, Terence P.; Schlichting, Douglas E.; Zuckerman, Steven H.; Emery, Paul 分享 收藏
Safety Profile of Baricitinib in Patients with Active Rheumatoid Arthritis with over 2 Years Median Time in Treatment Baricitinib治疗中位时间超过2年的活动性类风湿关节炎患者的安全性 Smolen, Josef S.; Genovese, Mark C.; Takeuchi, Tsutomu; Hyslop, David L.; Macias, William L.; Rooney, Terence; Chen, Lei; Dickson, Christina L.; Camp, Jennifer Riddle; Cardillo, Tracy E.; Ishii, Taeko; Winthrop, Kevin L. 分享 收藏
JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies Sanchez, Gina A. Montealegre; Reinhardt, Adam; Ramsey, Suzanne; Wittkowski, Helmut; Hashkes, Philip J.; Berkun, Yackov; Schalm, Susanne; Murias, Sara; Dare, Jason A.; Brown, Diane; Stone, Deborah L.; Gao, Ling; Klausmeier, Thomas; Foell, Dirk; De Jesus, Adriana A.; Chapelle, Dawn C.; Kim, Hanna; Dill, Samantha; Colbert, Robert A.; Failla, Laura; Kost, Bahar; O'Brien, Michelle; Reynolds, James C.; Folio, Les R.; Calvo, Katherine R.; Paul, Scott M.; Weir, Nargues; Brofferio, Alessandra; Soldatos, Ariane; Biancotto, Angelique; Cowen, Edward W.; Digiovanna, John J.; Gadina, Massimo; Lipton, Andrew J.; Hadigan, Colleen; Holland, Steven M.; Fontana, Joseph; Alawad, Ahmad S.; Brown, Rebecca J.; Rother, Kristina I.; Heller, Theo; Brooks, Kristina M.; Kumar, Parag; Brooks, Stephen R.; Waldman, Meryl; Singh, Harsharan K.; Nickeleit, Volker; Silk, Maria; Prakash, Apurva; Janes, Jonathan M.; Ozen, Seza; Wakim, Paul G.; Brogan, Paul A.; Macias, William L.; Goldbach-Mansky, Raphaela 分享 收藏
Pharmacokinetics, Pharmacodynamics, and Proposed Dosing of the Oral JAK1 and JAK2 Inhibitor Baricitinib in Pediatric and Young Adult CANDLE and SAVI Patients Kim, Hanna; Brooks, Kristina M.; Tang, Cheng Cai; Wakim, Paul; Blake, Mary; Brooks, Stephen R.; Sanchez, Gina A. Montealegre; de Jesus, Adriana A.; Huang, Yan; Tsai, Wanxia Li; Gadina, Massimo; Prakash, Apurva; Janes, Jonathan Marcus; Zhang, Xin; Macias, William L.; Kumar, Parag; Goldbach-Mansky, Raphaela 分享 收藏
CHARACTERIZATION OF CHANGES IN LYMPHOCYTE SUBSETS IN BARICITINIB-TREATED PATIENTS WITH EARLY, DMARD NAIVE, RHEUMATOID ARTHRITIS IN A PHASE 3 STUDY Takeuchi, T.; Fleischmann, R.; Schiff, M.; Issa, M.; Macias, W.; Rooney, T.; Zuckerman, S.; Schlichting, D.; McInnes, I. 分享 收藏
Effects of Baricitinib on Lipid, Apolipoprotein, and Lipoprotein Particle Profiles in a Phase IIb Study of Patients With Active Rheumatoid Arthritis Kremer, Joel M.; Genovese, Mark C.; Keystone, Edward; Taylor, Peter C.; Zuckerman, Steven H.; Ruotolo, Giacomo; Schlichting, Douglas E.; Crotzer, Victoria L.; Nantz, Eric; Beattie, Scott D.; Macias, William L. 分享 收藏
EX VIVO FUNCTIONAL COMPARISON OF BARICITINIB AND TOFACITINIB FOR CYTOKINE SIGNALLING IN HUMAN LEUKOCYTE SUBPOPULATIONS McInnes, Iain; Higgs, Richard; Rocha, Guilherme; Zhang, Xin; Lee, Jonathan; Wehrman, Thomas; Macias, William; Zuckerman, Steven; Taylor, Peter; Gentile, Maurizio 分享 收藏
Baricitinib, Methotrexate, or Combination in Patients With Rheumatoid Arthritis and No or Limited Prior Disease-Modifying Antirheumatic Drug Treatment Fleischmann, Roy; Schiff, Michael; van der Heijde, Desiree; Ramos-Remus, Cesar; Spindler, Alberto; Stanislav, Marina; Zerbini, Cristiano A. F.; Gurbuz, Sirel; Dickson, Christina; de Bono, Stephanie; Schlichting, Douglas; Beattie, Scott; Kuo, Wen-Ling; Rooney, Terence; Macias, William; Takeuchi, Tsutomu 分享 收藏
Baricitinib versus Placebo or Adalimumab in Rheumatoid Arthritis Taylor, Peter C.; Keystone, Edward C.; van der Heijde, Desiree; Weinblatt, Michael E.; del Carmen Morales, Liliana; Reyes Gonzaga, Jaime; Yakushin, Sergey; Ishii, Taeko; Emoto, Kahaku; Beattie, Scott; Arora, Vipin; Gaich, Carol; Rooney, Terence; Schlichting, Douglas; Macias, William L.; de Bono, Stephanie; Tanaka, Yoshiya 分享 收藏
SAFETY PROFILE OF BARICITINIB IN PATIENTS WITH ACTIVE RA: AN INTEGRATED ANALYSIS Smolen, J.; Genovese, M.; Takeuchi, T.; Hyslop, D.; Macias, W. L.; Rooney, T. P.; Chen, L.; Dickson, C.; Riddle, J.; Cardillo, T.; Winthrop, K. 分享 收藏
CHARACTERIZATION OF CHANGES IN LYMPHOCYTE SUBSETS IN BARICITINIB-TREATED PATIENTS WITH RHEUMATOID ARTHRITIS IN A PHASE 3 STUDY (RA-BEAM) Tanaka, Y.; Fleischmann, R.; Schiff, M.; Takeuchi, T.; Keystone, E.; Weinblatt, M.; Zuckerman, S.; Issa, M.; Thanabalasundrum, S.; Augendre-Ferrante, B.; de Bono, S.; Schlichting, D.; Rooney, T. P.; Macias, W. L.; Taylor, P. 分享 收藏
A randomized phase 2b trial of baricitinib, an oral Janus kinase (JAK) 1/JAK2 inhibitor, in patients with moderate-to-severe psoriasis Papp, K. A.; Menter, M. A.; Raman, M.; Disch, D.; Schlichting, D. E.; Gaich, C.; Macias, W.; Zhang, X.; Janes, J. M. 分享 收藏
Baricitinib in Patients with Refractory Rheumatoid Arthritis 难治性类风湿关节炎患者的Baricitinib Genovese, Mark C.; Kremer, Joel; Zamani, Omid; Ludivico, Charles; Krogulec, Marek; Xie, Li; Beattie, Scott D.; Koch, Alisa E.; Cardillo, Tracy E.; Rooney, Terence P.; Macias, William L.; de Bono, Stephanie; Schlichting, Douglas E.; Smolen, Josef S. 分享 收藏
分享 收藏
BARICITINIB, AN ORAL JANUS KINASE (JAK) 1/JAK2 INHIBITOR, IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS ( RA) AND AN INADEQUATE RESPONSE TO TNF INHIBITORS: RESULTS OF THE PHASE 3 RA-BEACON STUDY Genovese, M. C.; Kremer, J.; Zamani, O.; Ludivico, C.; Krogulec, M.; Xie, L.; Beattie, S.; Koch, A. E.; Cardillo, T.; Rooney, T.; Macias, W.; Schlichting, D.; Smolen, J. S. 分享 收藏
Safety and efficacy of baricitinib at 24 weeks in patients with rheumatoid arthritis who have had an inadequate response to methotrexate Keystone, Edward C.; Taylor, Peter C.; Drescher, Edit; Schlichting, Douglas E.; Beattie, Scott D.; Berclaz, Pierre-Yves; Lee, Chin H.; Fidelus-Gort, Rosanne K.; Luchi, Monica E.; Rooney, Terence P.; Macias, William L.; Genovese, Mark C. 分享 收藏
分享 收藏
.png){kind=icon}
未登录.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
